Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

27.79 -0.30 (-1.05%)
Streaming Delayed Price Updated: 3:48 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
System1 Group Revolutionizes Ads for Maximum Impact in 2024
James Gregory, the CEO of System1 Group Plc joins Steve Darling from Proactive to provide insights into the company's unique approach to advertising. System1 Group aims to assist the world's largest... 
Via TheNewswire.com
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - February 09, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via TheNewswire.com
Topics Lawsuit
Exposures COVID-19 Financial Legal
Why Is Moderna Stock Trading Lower Today?
Moderna long term data indicates a faster decline in efficacy for its RSV vaccine than the RSV vaccines from GSK and Pfizer. 
Via Benzinga
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Via Benzinga
S&P 500 rockets to new highs as earnings beat estimates
The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders. 
Via MarketBeat
Topics ETFs Earnings Stocks
Exposures Financial US Equities
3 Blue-Chip Stocks to Buy for High Total Returns by 2025
These undervalued blue-chip stocks represent fundamentally strong companies with healthy cash flow visibility. 
Via InvestorPlace
3 Value Stocks to Buy at 52-Week Low in February
Optimistic in 2024? Here are three of the best value stocks amid the market's cautious revival, offering strong upside potential. 
Via InvestorPlace
3 Blue-Chip Stocks to Buy at a 52-Week Low in February
Higher-for-longer interest rates and undervalued metrics make it a good time to look for blue-chip stocks at a low price. 
Via InvestorPlace
Pfizer's Problems Go Far Beyond Just Declining COVID Revenue
Can Pfizer's stock bounce back? 
Via The Motley Fool
Exposures COVID-19
2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine... 
Via Benzinga
Want to Earn $2,000 in Annual Dividend Income? Invest $33,000 in These 3 Stocks.
These dividend stocks haven't been great performers over the past year, but they could be excellent investments to buy and hold for the long run. 
Via The Motley Fool
3 Biotech Stocks to Buy on the Dip: February 2024
Here are three biotech stocks to buy that are trading at prices that may not account for potential breakthrough opportunities 
Via InvestorPlace
Want to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold Forever
Healthcare is an excellent place to find some tried and true wealth compounders. 
Via The Motley Fool
7 Retirement Stocks to Buy at 52-Week Lows
Markets may be at historic highs, but there are still plenty of high-quality retirement stocks to buy today at compelling valuations. 
Via InvestorPlace
Topics Retirement
Exposures Pension
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants 
Via TheNewswire.com
Exposures COVID-19
3 Reliable Dividend Stocks With Yields Above 6% That You Can Buy for Less Than $100 Right Now
You don't have to already be rich to start building a significant passive income stream. 
Via The Motley Fool
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
From Arvinas Inc.
Via GlobeNewswire
The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
Invest in the future with healthcare stocks 2024; offering a blend of market stability and cutting-edge medical advancements. 
Via InvestorPlace
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screaming Buys in February
These high-octane income stocks, which sport an average yield of 7.34%, can pad patient investors' pocketbooks. 
Via The Motley Fool
3 Sleeper Stocks to Buy for the Next Bull Run: February 2024
Embark on a savvy investing as we uncover three sleeper stocks and chart their stellar long-term potential to perform. 
Via InvestorPlace
3 Magnificent Stocks to Buy on the Dip: February 2024
Although the market doesn’t seem to appreciate these stocks to buy on dip, it’s missing out on potentially robust opportunities. 
Via InvestorPlace
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs. 
Via InvestorPlace
Markets suddenly price Eli Lilly stock for a breakout on earnings
The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up 
Via MarketBeat
Topics Bonds Economy
Exposures Debt Markets Interest Rates
Breaking Barriers in Cancer Care: The American Cancer Society and Pfizer Announce a $15 Million, Three-Year Initiative to Bridge the Gap in Cancer Care Disparities
From Pfizer Inc.
Via Business Wire
Better Dividend Stock: Pfizer vs. AbbVie
Both offer above-average yields but which can deliver the most dividend income over the long run? 
Via The Motley Fool
CytoReason's AI-Driven Disease Model Platform Trusted By 5 Top 10 Pharma Companies Harnesses Big Data To Speed Drug Discovery And Development
Click here to learn more about CytoReason and how to invest through OurCrowd.  
Via Benzinga
The Bull Market Left These 3 Stocks Behind, but They're Buys Right Now
Sometimes, undervalued market laggards have what it takes to catch up over the long haul. 
Via The Motley Fool
1 Beaten-Down Dividend Stock to Avoid in 2024, and 1 to Consider Buying and Holding Forever
These two companies have dramatically different futures in store. 
Via The Motley Fool
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.